In mice bearing 4T1 tumor cells, inhibiting CD8+ T-cells has reversed the miR-3609-mediated improved survival, indicating that miR-3609 can exert the tumor suppressor role via inhibiting tumoral PD-L1 expression and inducing the pro-inflammatory tumor microenvironment [37]. The gene discussed is CD8A; the disease is neoplasm.